Patents by Inventor Simon Strass

Simon Strass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260217702
    Abstract: Substituted imidazoquinoline ligands to TLR7 and 8 that up-regulate interferon production with improved specificity vs. existing ligands. The compounds exhibit improved pharmacokinetics and distribution properties and are well tolerated in vivo. They are suitable for use in therapeutics for infectious and neoplastic diseases.
    Type: Application
    Filed: December 22, 2023
    Publication date: July 30, 2026
    Applicant: Synovo GmbH
    Inventors: Manuel Keppler, Simon Strass, Christiane Baeuerlein, Jan-Hinrich Guse, Mary Eggers, Martin Reisser, Michael W. Burnet, Sophia Geiger
  • Publication number: 20230159581
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: July 26, 2022
    Publication date: May 25, 2023
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Patent number: 11420995
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: August 23, 2022
    Assignee: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Publication number: 20200262857
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: March 2, 2018
    Publication date: August 20, 2020
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass